Pharmaceutical Firm CSPC Innovation Submits Renewed Listing Application to Hong Kong Exchange

Stock News06-20

Information indicates that on June 18, the Hong Kong Stock Exchange disclosed a listing application from Cspc Innovation Pharmaceutical Co.,Ltd. (300765.SZ), targeting the Main Board, with CITIC Securities serving as its exclusive sponsor. The company had previously submitted an application for listing on December 10, 2025. According to the prospectus, data from Frost & Sullivan shows that from 2020 to 2025, Cspc Innovation Pharmaceutical Co.,Ltd. maintained its position as the world's largest producer of chemically synthesized caffeine by revenue and shipment volume. The company's primary product is caffeine used as a food additive in functional beverages.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment